Runben Biotechnology Statistics
Total Valuation
SHA:603193 has a market cap or net worth of CNY 14.11 billion. The enterprise value is 13.72 billion.
Market Cap | 14.11B |
Enterprise Value | 13.72B |
Important Dates
The next estimated earnings date is Friday, April 25, 2025.
Earnings Date | Apr 25, 2025 |
Ex-Dividend Date | Oct 30, 2024 |
Share Statistics
SHA:603193 has 404.59 million shares outstanding. The number of shares has increased by 19.70% in one year.
Current Share Class | n/a |
Shares Outstanding | 404.59M |
Shares Change (YoY) | +19.70% |
Shares Change (QoQ) | -4.62% |
Owned by Insiders (%) | 30.08% |
Owned by Institutions (%) | 7.89% |
Float | 75.42M |
Valuation Ratios
The trailing PE ratio is 45.93 and the forward PE ratio is 44.97.
PE Ratio | 45.93 |
Forward PE | 44.97 |
PS Ratio | 11.32 |
PB Ratio | 6.91 |
P/TBV Ratio | 6.98 |
P/FCF Ratio | 72.66 |
P/OCF Ratio | 58.31 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 42.38, with an EV/FCF ratio of 70.64.
EV / Earnings | 44.81 |
EV / Sales | 11.00 |
EV / EBITDA | 42.38 |
EV / EBIT | 45.68 |
EV / FCF | 70.64 |
Financial Position
The company has a current ratio of 10.60, with a Debt / Equity ratio of 0.00.
Current Ratio | 10.60 |
Quick Ratio | 2.37 |
Debt / Equity | 0.00 |
Debt / EBITDA | 0.01 |
Debt / FCF | 0.02 |
Interest Coverage | 1,897.11 |
Financial Efficiency
Return on equity (ROE) is 20.79% and return on invested capital (ROIC) is 12.71%.
Return on Equity (ROE) | 20.79% |
Return on Assets (ROA) | 11.71% |
Return on Invested Capital (ROIC) | 12.71% |
Return on Capital Employed (ROCE) | 14.70% |
Revenue Per Employee | 1.36M |
Profits Per Employee | 333,890 |
Employee Count | 917 |
Asset Turnover | 0.78 |
Inventory Turnover | 4.67 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +93.72% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +93.72% |
50-Day Moving Average | 32.47 |
200-Day Moving Average | 24.20 |
Relative Strength Index (RSI) | 54.69 |
Average Volume (20 Days) | 3,706,272 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603193 had revenue of CNY 1.25 billion and earned 306.18 million in profits. Earnings per share was 0.76.
Revenue | 1.25B |
Gross Profit | 722.73M |
Operating Income | 300.33M |
Pretax Income | 354.77M |
Net Income | 306.18M |
EBITDA | 321.70M |
EBIT | 300.33M |
Earnings Per Share (EPS) | 0.76 |
Balance Sheet
The company has 396.33 million in cash and 3.11 million in debt, giving a net cash position of 393.21 million or 0.97 per share.
Cash & Cash Equivalents | 396.33M |
Total Debt | 3.11M |
Net Cash | 393.21M |
Net Cash Per Share | 0.97 |
Equity (Book Value) | 2.04B |
Book Value Per Share | 5.04 |
Working Capital | 1.68B |
Cash Flow
In the last 12 months, operating cash flow was 242.04 million and capital expenditures -47.81 million, giving a free cash flow of 194.22 million.
Operating Cash Flow | 242.04M |
Capital Expenditures | -47.81M |
Free Cash Flow | 194.22M |
FCF Per Share | 0.48 |
Margins
Gross margin is 57.96%, with operating and profit margins of 24.09% and 24.55%.
Gross Margin | 57.96% |
Operating Margin | 24.09% |
Pretax Margin | 28.45% |
Profit Margin | 24.55% |
EBITDA Margin | 25.80% |
EBIT Margin | 24.09% |
FCF Margin | 15.58% |
Dividends & Yields
This stock pays an annual dividend of 0.18, which amounts to a dividend yield of 0.55%.
Dividend Per Share | 0.18 |
Dividend Yield | 0.55% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | 22.46% |
Buyback Yield | -19.70% |
Shareholder Yield | -19.16% |
Earnings Yield | 2.17% |
FCF Yield | 1.38% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SHA:603193 has an Altman Z-Score of 26.32.
Altman Z-Score | 26.32 |
Piotroski F-Score | n/a |